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Background: Deciphering avenues to adequately control malignancies in the peripheral
nerve will reduce the need for current, largely-ineffective, standards of care which
includes the use of invasive, nerve-damaging, resection surgery. By avoiding the
need for en bloc resection surgery, the likelihood of retained function or efficient
nerve regeneration following the control of tumor growth is greater, which has several
implications for long-term health and well-being of cancer survivors. Nerve tumors can
arise as malignant peripheral nerve sheath tumors (MPNST) that result in a highly-
aggressive form of soft tissue sarcoma. Although the precise cause of MPNST remains
unknown, studies suggest that dysregulation of Schwann cells, mediated by the
microenvironment, plays a key role in tumor progression. This study aimed to further
characterize the role of local microenvironment on tumor progression, with an emphasis
on identifying factors within tumor suppressive environments that have potential for
therapeutic application.
Methods: We created GFP-tagged adult induced tumorigenic Schwann cell lines
(iSCs) and transplanted them into various in vivo microenvironments. We used
immunohistochemistry to document the response of iSCs and performed proteomics
analysis to identify local factors that might modulate divergent iSC behaviors.
Results: Following transplant into the skin, spinal cord or epineurial compartment of the
nerve, iSCs formed tumors closely resembling MPNST. In contrast, transplantation into
the endoneurial compartment of the nerve significantly suppressed iSC proliferation.
Proteomics analysis revealed a battery of factors enriched within the endoneurial
compartment, of which one growth factor of interest, ciliary neurotrophic factor (CNTF)
was capable of preventing iSCs proliferation in vitro.
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Conclusions: This dataset describes a novel approach for identifying biologically
relevant therapeutic targets, such as CNTF, and highlights the complex relationship
that tumor cells have with their local microenvironment. This study has significant
implications for the development of future therapeutic strategies to fight MPNSTs, and,
consequently, improve peripheral nerve regeneration and nerve function.
Keywords: peripheral nerve, sarcoma, Schwann cell, MPNST, CNTF, endoneurium, epineurium, microenvironment
IMPORTANCE OF STUDY
These studies provide several major findings. First, we develop
a reproducible in vitro model to study MPNST from isolated
adult rodent Schwann cells (termed iSCs) that following
transplantation, share striking phenotypic resemblance to human
MPNST tumors. Second, our results underscore the importance
of tissue microenvironment in promoting tumorigenic growth
and identify the endoneurial compartment within the peripheral
nerve as a unique microenvironment enriched in tumor
suppressive factors. Third, by probing uniquely expressed
proteins within the endoneurial compartment, we demonstrated
an autonomous role for CNTF to block proliferation of iSCs
mimicking the inhibition observed when grafted iSCs are
contained within the endoneurial compartment in vivo. Together,
these experiments provide evidence for a tumor suppressive
endoneurial niche that functions to repress proliferation and
identifies CNTF signaling as a potential therapeutic avenue for
MPNST.
INTRODUCTION
Malignancies within the peripheral nerve usually arise from
aberrant Schwann cell proliferation (Miller et al., 2006; Chen
et al., 2014) giving rise to malignant peripheral nerve sheath
tumors (MPNST), a highly aggressive and largely untreatable
form of soft tissue sarcoma, often culminating in patient death
within ten years(LaFemina et al., 2013). MPNSTs occur in
association with inherited syndromes, such as Neurofibromatosis
Type 1 (NF1) but can also occur sporadically (46–48% of
cases) (LaFemina et al., 2013). Although numerous treatment
modalities have been assessed for treating MPNSTs (i.e., radiation
therapy, surgical resection) they show moderate to poor results
long term (LaFemina et al., 2013).
Deciphering avenues to adequately control malignancies in
the peripheral nerve will potentially improve the current standard
of care. More effective adjunctive drug therapy may allow
modification of en block procedures, toward a nerve-sparing
approach, to permit function to be retained.
There is strong evidence to suggest that distinct locations
within the peripheral nervous system are prone to tumor
formation and progression. For example, several studies have
reported the capacity of nerve sheath tumors to form, with
increased tumor burden, within the proximal nerves and
plexus compared to the distal nerves (Plotkin et al., 2012)
and are increasingly metastatic in the intrathoracic and dorsal
root ganglion (DRG) regions compared to subdiaphragmatic
regions (Kourea et al., 1998). One potential difference between
these anatomical regions is the presence of distinct local
microenvironments unique to each location (Le et al., 2010;
Lavasani et al., 2013). Moreover, transplanting NF1-mutant cells
into several distinct locations within healthy rodents revealed that
aberrant cell growth was especially pronounced when introduced
into distinct regions (Le et al., 2010). The factors responsible for
these divergent effects remain to be elucidated.
In line with this, others have observed similar phenomena
following injury (Ribeiro et al., 2013; Schulz et al., 2016).
Recently, Ribeiro and his colleagues found that when NF1
mutation was induced in adult Schwann cells, tumors formed
in the nerve, but intriguingly only post-injury, and were
restricted only to the injury site. In this context, the authors
concluded that tumor formation must involve an interplay
between Schwann cell-associated NF1 mutation and injury
environments. They suggested that although the nerve is
generally a “tumor suppressive environment,” an insult can
locally alter the composition and concentration of factors
present at the injury site, consequently allowing unregulated
cell growth. Indeed, cytokine-releasing mast cells at the
injury site have been shown to play a role in nerve tumor
progression by introducing factors that are not typically present
within the intact nerve (Yang et al., 2008). Importantly, the
authors also noted that tumors did not form distal to the
injury site – an area of the nerve that undergoes Wallerian
degeneration post-injury. Since this area is subjected to similar
injury cues, including the presence of mast cells (Gaudet
et al., 2011), such findings suggest that injury-associated
factors are not the sole mediators of tumorigenicity in this
context.
Another plausible explanation for the formation of tumors
at the injury site is the breakdown of connective tissue barriers
as a result of the mechanical force exerted at the injury site
itself (Olsson and Kristensson, 1973). The perineurial barrier, a
thin layer of perineurial cells and collagen (Riccardi, 2007), acts
as a specialized blood-nerve barrier in health (similar to that
of the central nervous systems blood-brain barrier) (Allt and
Lawrenson, 2000), but becomes compromised at sites of nerve
injury (Haftek and Thomas, 1968). In homeostatic conditions,
this specialized perineurial barrier with tight junctions prevents
components from the endoneurium, where axons and Schwann
cells reside, to diffuse freely into the epineurium, where large
amounts of connective tissue resides (Olsson and Kristensson,
1973), as well as vice versa. Importantly, long term compromised
perineurial barrier function post-injury is spatially confined only
to the site of injury and does not extend distally (Olsson and
Kristensson, 1973).
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The potential contribution of a compromised barrier function
to tumor progression becomes especially plausible when the types
of cells and factors present within each defined compartment
are considered. The epineurium harbors fibroblasts, adipocytes,
endothelial cells, blood vessels, mast cells and large amounts
of collagen (Norris et al., 1985; Verheijen et al., 2003). On
the other hand, the endoneurial compartment mainly harbors
Schwann cells (90%) and axons as well as a small number of
neural-crest derived fibroblasts, endothelial cells, immune cells
and small amounts of collagen (Sunderland, 1945; Riccardi, 2007;
Weiss et al., 2016). Interestingly, several studies have shown
that factors/cells known to be present within the epineurium
enhance tumor progression (Fang et al., 2014; Kuzet and
Gaggioli, 2016; McDonald et al., 2016), while several factors
known to be present within the endoneurial compartment
suppress Schwann cell proliferation (Parrinello et al., 2008).
As such, one might hypothesize that Schwann cell-derived
tumorigenesis is a consequence of perineurium breakdown
and consequent exposure of latent tumorigenic cells to factors
previously restricted to the epineurial compartment competing
with suppressive factors within the endoneurium.
To elucidate the role of microenvironment on tumor
progression, we subjected healthy adult Schwann cells to a
mutagenic environment in vitro following which they were
transplanted into various in vivo anatomical microenvironments.
Following transplantation, mutagenic Schwann cells share
striking phenotypic resemblance to human MPNST tumors.
Intriguingly, when these same mutagenic induced tumor
Schwann cells (iSCs) are injected and contained within the
endoneurial compartment, they exit cell cycle and down-regulate
tumor markers. Using quantitative proteomics to screen for
factors that were uniquely present within the endoneurial
compartment, we identified ciliary neurotrophic factor (CNTF), a
growth factor known for promoting Schwann cell differentiation
(Reynolds and Woolf, 1993), as a factor that was not only
enriched within the endoneurium, but exhibited an autonomous
capacity to inhibit proliferation of mutagenic Schwann cells.
Uncovering the signals in the endoneurial niche that bias
Schwann cells against hyperproliferation can safeguard against
nerve malignancies and pave the path for regeneration and return
of nerve function for cancer survivors.
MATERIALS AND METHODS
In vitro Induction of Tumor-Forming
Adult Schwann Cells (iSCs)
Sciatic nerves were collected from three adult Sprague Dawley
rats, then Schwann cells were isolated using a modified protocol
from previously described methods (Mirfeizi et al., 2017). Briefly,
nerves were dissected and minced, and subsequently incubated
in collagenase Type IV (Worthington) at 37◦C for 40 min.
Samples were then centrifuged (1000 rpm for 5 min), then
re-suspended in Schwann cell media containing DMEM and
F12 (3:1), neuregulin-1 type III (50 ng/ml), forskolin (5 µM),
B27 supplement (1%), and penicillin (100 µg/ml)/streptomycin
(100 units/ml). Cells were plated on poly-D-Lysine (20 µg/ml)
and laminin (4 µg/ml) coated surfaces (BD Bioscience) and
cultured at 37◦C in a 5% CO2 incubator. Cultures were
also supplemented with plasmocin (25 µg/mL, Invitrogen)
and fungizone (40 ng/ml, Invitrogen) for the first month of
culturing to prevent mycoplasma and fungal growth. Triple-
filtered fetal bovine serum (1–5% FBS; Hyclone) was added for
the first 5 days of culturing. Cells were maintained in vitro for
3–4 months. For passaging, media was removed and TrypLE-
express (Invitrogen) was added to cultures and incubated at 37◦C
for 5 min. All detached cells were collected and plated at a density
of 50,000 cells/ml for further maintenance. Tumor-forming
characteristics of adult Schwann cells were induced by extended
growth and repeated passage in vitro as previously described
(Funk et al., 2007). Spherical colony formation (loss of contact
mediated growth inhibition) and growth factor independence
was observed by 3 months in culture. Cells were fed every 4th
day and treated identically.
Lenti-Viral Labeling
To track cells following in vivo transplantation, cells were
transduced with a GFP-expressing lenti-viral vector as previously
described (Mirfeizi et al., 2017). All lentivirus work was
undertaken in a biohazard level 2+ laboratory using previously
established protocols. Cells (70% confluence) were incubated
overnight in DMEM containing GFP-expressing lentiviral
particles and polybrene (8 µg/ml). The next day, fresh media was
applied and cells were left to grow to 100% confluence. Cells were
then dissociated and FACs sorted (BD FACS Aria III) to further
purify the GFP+ cell fraction.
Karyotyping
To assess chromosomal integrity, karyotyping was performed
on iSCs using previously described methods (Fan et al.,
2014). Cultures (70% confluence) were treated with KaryoMAX
Colcemid solution (30 ng/mL, Gibco) for 4 h at 37◦C. Schwann
cells were then detached from dishes, centrifuged, then re-
suspended in cell hypotonic solution (CHS; 40 mM Kcl, 20 mM
HEPES, 0.5 mM EGTA and 9 mM NaOH) and incubated for 1 h
at 37◦C. After 1 h, the mix was fixed with acetic acid/methanol
(1:3) and G-banding analysis was performed in the Clinical
Genetics Facility at the Alberta Children’s Hospital.
In vitro Treatments,
Immunocytochemistry and Imaging
To assess the response of iSCs to different environmental stimuli,
iSCs were plated onto 96-well plates at 10,000 cells/mL. Cells
were treated with base media in the presence of neuregulin
(100 ng/ml, R&D), CNTF (0–100 ng/ml, Peprotech), or media
pre-conditioned with epineurial tissue, endoneurial tissue or
spinal cord tissue. To prepare media for conditioned media
experiments, equal wet weights of healthy epineurial tissue or
endoneurial tissue from sciatic nerves, or white matter from
thoracic spinal cords was dissected from C57BL/6 mice (n = 8–
10), then maintained in DMEM and F12 (3:1), B27 supplement
(1%), penicillin (100 µg/ml)/streptomycin (100 units/ml) and
10% FBS for 4–6 days before filtering (0.4 µm), and snap
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freezing at −80◦C until iSCs 96-well experiments were ready.
Depleted media alone controls were treated identically except
no explants were added. Three days post-treatment, cells were
washed with sterile PBS and then fixed in 4% paraformaldehyde
(PFA) for 5–10 min. For immunocytochemistry, cells were
permeabilized using 0.5% triton X-100 and 5% BSA for 1–
2 h at room temperature. Primary antibodies (rat anti-Ki67
(clone SolA15, 14569882, eBiosciences), mouse anti-nestin
(SC23927, Santa Cruz) were incubated overnight (1:200) at
room temperature. Unbound primary antibodies were washed
and cells were subsequently incubated with Alexa-conjugated
secondary antibodies (1:200, Invitrogen) at room temperature
for 1–2 h, washed, and nuclei were counterstained with Hoechst
(1:1000, Sigma) and imaged using ImageXpress (Molecular
Devices). The sum of cells (Ki67+ NES+ Hoechst+ versus
NES+ Hoechst+) in 12 images (20×) per well was obtained,
then normalized to obtain a percentage value for each well.
This value was subsequently averaged across three replicates
per condition. Experiments were replicated on 3 independent
days.
Animal Care and Surgery
Animal procedures were approved by the University of Calgary
and University of British Columbia Animal Care Committees
in compliance with the Guidelines of the Canadian Council of
Animal Care. To assess the impact of in vivo microenvironments
on the capacity of iSCs to form tumors, adult 8–12 weeks
immune-deficient Foxn1nu, NOD/CB17-Prkdcscid/NcrCrl mice
(for nerve and skin injections), or Sprague Dawley rats (for
spinal cord injections) were used [Charles River Laboratories
(Senneville, QC, Canada)]. Rats were treated with Cyclosporin A
and GM1 natural killer cell antibodies for immunosuppression.
Rodents were maintained on a 12-h light cycle in a temperature-
controlled environment with unlimited food and water. For
cell transplants, rodents were anesthetized using isofluorane
(5% induction and 2% maintenance) and given subcutaneous
injections of 0.1 mL (0.03 mg/mL) buprenorphine for pain relief.
For nerve and spinal cord transplants, an injury was first induced
prior to transplants in order to create an environment permissive
for tumor formation (Ribeiro et al., 2013). Surgery sites were
sterilized and then the sciatic nerve (including endoneurial and
epineurial compartments) or spinal cords were exposed and
crush injured using #5 forceps (nerve) or an Infinite Horizon
Impactor, 200 KD (spinal cord). Immediately after (nerve) or
2 weeks after (spinal cord) injury, each distal nerve received
a 2 µl volume injection (100,000 cells) and each spinal cord
received a 5 µl volume injection (500,000 cells) of GFP+ve
nerve or skin-derived iSCs (n = 3–4 rodent per donor, 2–3
donors) using a 33-gauge Hamilton syringe. iSCs were suspended
in neuregulin (500 ng/ml) and fast green (1%) in DMEM
at a density of 50,000 cells/µl. Importantly, this injection
strategy resulted in the presence of iSCs in the endoneurial
(tibial fascicles) and epineurial (surrounding the fascicles)
compartments. For skin transplants, GFP transduced iSCs
were injected intradermally into the back skin of NOD/CB17-
Prkdcscid/NcrCrl mice. In all cases, tissue was collect within
2–4 months of surgeries.
Tissue Processing,
Immunohistochemistry and Imaging
Briefly, nerve, skin, and spinal cord tissue was harvested at 2–
4 months post-transplant, then fixed overnight with 4% PFA.
For spinal cords, 4% PFA cardiac perfusion was also performed.
Tissue was then left in 30% sucrose overnight, then frozen in OCT
(VWR International) and stored at −80◦C. For comparisons
to MPNST, archived human and rodent samples were fixed
overnight in 10% neutral buffered formalin, processed through
graded ethanol’s and xylene, and embedded in paraffin. Sections
were cut at 4 µm thickness and stained with hematoxylin
and eosin (H&E). For IHC, heat-induced antigen retrieval was
performed in 10 mM sodium citrate for 25 min in microwave
prior to staining with the following primary antibodies: S100
(DAKO) rabbit polyclonal 1:3,000 dilution and Desmin (DAKO)
mouse monoclonal D33 1:400 dilution. Detection of staining was
performed using Envision+DAB kit (DAKO) per manufacturer’s
protocol with hematoxylin as a counterstain. Archival material
from MPNST surgical samples were obtained from the Clark
Smith Tumor Bank at the University of Calgary (in collaboration
with Calgary Laboratory Services) with ethics approval from the
Health Research Ethics Board of Alberta – Cancer Committee.
For immmunohistochemitry for PFA fixed tissue, sections were
cut using a Leica cryotome at 10–20 µm. Sections were
then permeabilized with 0.5% triton-X 100 and blocked with
5% BSA or 10% NDS. Primary antibodies were incubated
overnight (rabbit anti-Ncad, AB12221 Abcam; rat anti-Ki67,
14569882, eBiosciences; goat anti-CNTF, AB557 R&D; sheep
anti-ErbB3, AF4518 R&D), washed with PBS, and then Alexa-
conjugated secondary antibodies (1:200, Invitrogen) were applied
for 2 h at room temperature. Hoechst was used to stain nuclei
(1:1000, Sigma) and mounted with Permafluor (Thermo Fisher
Scientific). Image collection and quantification was done using
a Leica SP8 confocal microscope. Two images per condition
at 4 mm distal to the injury site was collected using a
63× objective lens and Z-stack (eight planes) features. Images
(maximum projection) were analyzed using ImageJ (NIH). These
counts were then expressed as a ratio (i.e., GFP+ve Ki67+ve
cells/GFP+ve cells) and averaged within each animal (n = 5
animals/group).
Proteomics
In order to assess the protein composition of the fascicular
portion of the nerve, sciatic nerves were firstly extracted
from healthy adult C57BL/6 mice (n = 8). Using fine forceps
the outer sheaths (ie. epineurium and perineurium) of the
sciatic nerves were carefully removed. At this stage the
contents of the endoneurium (individual myelinated axons) were
clearly distinguishable, and were minced and incubated before
processing for protein collection. Equal wets weights of the
dorsal column from the same mice were also collected as a
comparison. Protein was extracted with SDS gel sample buffer
[0.2 M Tris, 5 mM EDTA, 1 M Sucrose, SDS and dithiothreitol
(DTT)]. Protein was then run on 10% acrylamide gel containing
SDS to separate out proteins that were most likely of interest
(10–60 kDa).
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Gel plugs were washed in 50 mM ammonium
bicarbonate/acetonitrile (50:50, v/v) then incubated in 100%
acetonitrile. After being air dried, proteins were reduced with
DTT (10 mM) at 56◦C and alkylated with iodoacetamide
(50 mM) at 24◦C. Gel plugs were washed then rehydrated with
a trypsin solution (Promega; 0.02 µg/ul, 10% acetonitrile) for
2 h at 0◦C then placed in buffer for 16 h at 37◦C. Supernatant
(tryptic peptides) was transferred to acidifying solution
[acetonitrile/water/10% trifluoroacetic acid (60:30:10, v/v)].
Gel plugs were washed with the same acidifying solution and
combined. Samples were then lyophilized and resuspended in
1% formic acid. The tryptic peptides were analyzed by liquid
chromatography (LC; Agilent 1260 Infinity chip cube interface)
tandem mass spectrometry (MS/MS) on an Agilent 6550 iFunnel
quadrupole (Q)- time-of-flight (TOF) mass spectrometer.
The LC and the Q-TOF were both controlled by MassHunter
(B.05.00). The capillary pump used: A1 (97% water, 2.9%
acetonitrile, 0.1% formic acid) and B1 (90% acetonitrile, 9.9%
water; 0.1% formic acid) solutions; and, the nanopump used: A1
(97% water, 2.9% acetonitrile, 0.1% formic acid) and B1 (97%
acetonitrile, 2.9% water; 0.1% formic acid) solutions. Tryptic
peptides (1 µl) were loaded onto a C18 trap column of an Agilent
chip operating in enrichment mode using the capillarity pump of
the LC system at a flow rate of 2.5 µl/min. Elution of the peptides
was performed using a 25 min linear gradient from 3% to 50% B1
generated by the nanopump operated at 0.3 µl/min. The peptides
were electrosprayed into the Q-TOF using an ionization voltage
of 1950V and a 275◦C heated drying gas at a flow of 13 l/min.
The Q-TOF was operated in positive auto MS/MS mode. The
precursor ions with a m/z comprised between 275 and 1700 were
acquired at a scan rate of 250 ms/spectrum and the 10 most
abundant precursors for each cycle having a charge higher than 1,
an intensity of at least 1000 counts and a peptidic isotopic model
were fragmented by collision induced dissociation. Fragment
ions having a m/z comprised between 50 and 1700 were acquired
at a scan rate of 333.3 ms/spectrum. The collision energy was
calculated for each precursor based on its charge and its mass. An
active exclusion which was released after 1 spectrum and 0.2 min
was applied to avoid re-acquiring the same precursor.
For data extraction, a peptidic isotopic model with a
maximum charge state of 6 was used. The peak filtering for
MS/MS data was set up at an absolute height of at least 10
counts and relative height of the most abundant peak of at least
0.1%. Using Mascot algorithm (2.4), NCBI database search was
performed. Parameters included: trypsin as enzyme, maximum
number of missed cleavage of 1, a peptide charge of 2+, 3+,
and 4+, cysteine carbamidomethylation as fixed modification,
methionine oxidation as variable modification and a mass error
tolerance of 20 ppm. A mass error tolerance of 0.2 Da was
selected for the fragment ions. Only peptides identified with a
score having a confidence higher than 95% were kept for further
analysis.
Statistical Analysis
All statistical analysis was performed using GraphPad Prism
(v5.0). Statistical comparisons were performed using a
two-tailed unpaired Student’s t-test or One-way ANOVA
followed by Tukey’s posthoc test. A p-value of <0.05 was
considered statistically significant. All graphs are presented as
mean± standard error of mean (SEM).
RESULTS
The Development of a Model for MPNST
To develop an MPNST model, we isolated primary Schwann
cells from adult uninjured nerves (n = 3) and subjected these
cells to identical mutagenic in vitro conditions as described by
Funk and colleagues rodent experiments (Funk et al., 2007).
Following 3–4 months of in vitro processing, adult Schwann cells
consistently demonstrated features typical to tumor cell lines,
including growth factor independent growth, loss of contact-
mediated growth suppression, and abnormal chromosomes
(Figure 1). Immunocytochemical assessment of proliferation
kinetics indicated that iSCs were capable of proliferating at
similar rates even in the absence of growth factors (neuregulin
and forskolin; Figures 1A,B); indicating a loss of growth factor-
dependent growth (Funk et al., 2007). Subsequent quantification
revealed that the percentage of Ki67+ iSCs did not statistically
differ between iSCs cultured in the presence or absence of growth
factors critical to SC survival (Student’s t-test, n = 4, p = 0.3).
Also, iSCs formed non-adherent spherical colonies indicating
a loss of contact-mediated cell cycle arrest—another common
feature of uncontrolled proliferation (Figure 1C). Finally,
we also demonstrated that there were several chromosomal
abnormalities, including polyploidy and monosomy present
within all iSC cultures (Figure 1D). Together, such findings
indicate that Schwann cells exposed to extended in vitro cell
culture exhibit reproducible transformation of otherwise healthy
Schwann cells.
In order to determine the subtype of tumors generated by
iSCs, we assessed several in vivo features of iSC-generated
tumors following transplantation into the skin and compared
these to human MPNST tumor biopsies collected at the Clark
Smith Tumor Bank at the University of Calgary. Following
subcutaneous injection of iSCs, 10/12 (83%) of cases showed
a dermal growth at the injection site (Figure 1E). Consistent
with MPNST (Figure 1F–I), iSC-generated tumors consisted
of solid sheets and fascicles comprising elongated spindled
cells with enlarged atypical oval and tapered nuclei, and
moderate amounts of cytoplasm (Figures 1J,K). Tumor cells were
mitotically active and displayed foci of intratumoral necrosis.
Immunohistochemical staining showed that the tumor cells
were focally immunoreactive for S100 (Figure 1L) and were
negative for desmin (Figure 1M). Together, the histologic
and immunophenotypic findings of iSC-generated tumors
recapitulate those of human MPNST.
Endoneurial Microenvironment
Suppresses Tumorigenesis of MPNST
To assess the effect of distinct nerve microenvironments on iSC
tumor progression, GFP-labeled iSCs were injected into specific
compartments (eg. endoneurium and epineurium) within the
sciatic nerves of immune deficient rodents. Within 2 months
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FIGURE 1 | The development of a malignant peripheral nerve sheath tumors (MPNST) model. (A) Representative immunocytochemical images of induced tumor
Schwann cells (iSCs) either deprived of growth factors (–NRG) or treated with neuregulin and forskolin (+NRG, 50 ng/ml neuregulin, 5 mM Forskolin). Note the similar
numbers of Nestin+ (green, NES), Hoechst+ (blue) iSCs that express Ki67 (red) across both conditions. (B) Quantification of percentage of Ki67+ cells revealed no
difference between groups (Student’s t-test, n = 4, P = 0.3). (C) Note the presence of sphere formation when iSCs are grown in growth factor deprived conditions.
(D) Karyotyping analysis indicates multiple chromosomal abnormalities, including polyploidy and monosomy cells. (E) Intradermal iSC injections into back skin
resulted in the development of tumors within 16 weeks. (F–M) Representative histological images of H&E (F,G,J,K), s100 (H,L) and Desmin (I,M) from a biopsied
sample of human MPNSTs (F–I) and from a sample from iSCs (J–M). Note the presence of necrosis, mitosis and spindle-shaped cells in both samples (F,G and
J,K). Also note the presence of S100 (H,L) immunoreactivity, as well as the lack of Desmin immunoreactivity (I,M) in both samples. Scale bars = A (50 µm), C
(200 µm), G–I (20 µm).
post-transplant, in 88% of cases (8/9 animals), we observed
the formation of tumors (Figure 2A). Importantly, there was
a robust presence of Ki67+ GFP+ iSCs (Watanabe et al.,
2001) and their location was strictly confined to the epineurial
compartment (Figure 2B). Quantification of the percentage
of Ki67+ GFP+ iSCs demonstrated a fourfold decrease in
proliferation in the endoneurial compartment compared to the
epineurial compartment (One-way ANOVA with Tukey’s posthoc
test, n = 6, p < 0.001, Figure 2E). We also noted reduced
expression of other cancer-associated proteins in iSCs within
the endoneurial compartment compared to those within the
epineurial compartment, including ErbB3 (Stonecypher et al.,
2005) and N-cadherin (Flaiz et al., 2008), both associated
with dysregulated growth factor signaling in tumor growth
(Aplin et al., 1998; Hanahan and Weinberg, 2000) (Figure 3).
We also performed identical injections of iSCs into the spinal
cord. Similar to the epineurial compartment, highly proliferative
and invasive iSC tumors formed in 88% of cases (9/10)
(Figures 2C–E).
Finally, we asked whether secreted factors may be responsible
for this context-dependent growth inhibition. To do this,
we exposed iSCs to conditioned media from microdissected
adult nerve endoneurium, epineurium or spinal cord tissues.
Intriguingly, there was a ∼40% reduction in the percentage
of proliferative iSCs when subjected to conditioned media
from endoneurial tissue compared to media conditioned with
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FIGURE 2 | The endoneurial microenvironment suppresses tumorigenesis of MPNST. (A) Intraneural iSC injections into the sciatic nerve resulted in the development
of tumors within 2 months. (B) Representative immunohistochemical images of the endoneurial and epineurial compartments. Note the presence of widespread
Ki67+ (red), Hoechst+ (blue) proliferative iSC (green) in the epineurial compartment compared to the endoneurial compartment. See inset (ˆˆ) for high-resolution
example of localization (arrowheads). (C) iSCs injected into the dorsal column of the spinal cord formed tumors within 2 months. (D) Representative
immunohistochemical images of the spinal cord. Note the presence of widespread Ki67+ (red), Hoechst+ (blue) proliferative iSC (green) in the spinal cord. See inset
(∗∗) for high-resolution example of localization (arrowheads). (E) Quantification of the percentage of Ki67+ iSCs in the endoneurial compartment, epineurial
compartment and spinal cord demonstrated a significant decrease in endoneurial compartment compared to other regions (One-way ANOVA, Tukey’s posthoc test,
n = 6–8, ∗p < 0.01, ∗∗p < 0.001). (F) Representative immunocytochemical images of iSCs treated with conditioned media (CM). Note there are less Ki67+ (red)
Hoechst+ (blue) iSCs in the cultures treated with endoneurial CM compared to epineurial, spinal cord or base media. (G) Quantification of the percentage of Ki67+
iSCs demonstrated a significant decrease in the percentage of Ki67+ iSCs under endoneurial CM conditions compared to all other groups (One-way ANOVA,
Tukey’s posthoc test, n = 3, ∗∗∗∗p < 0.0001, ∗∗∗p < 0.001, ∗∗p < 0.01). Scale bars = B (50 µm), E (20 µm), F (50 µm).
epineurium or spinal cord tissue homogenates (One-way
ANOVA, Tukey’s posthoc test, n = 3, endoneurium vs; depleted,
p < 0.0001; spinal cord, p < 0.001; epineurium, p < 0.01,
Figures 2F,G). Taken together, these findings suggest that
endoneurial microenvironments are uniquely suppressive for
Schwann cells predisposed for oncogenic growth.
The Identification of Suppressive Factors
in the Endoneurial Compartment
To identify potential repressive signaling proteins (10–60 kDa)
enriched in endoneurial tissue of the adult mouse sciatic nerve
we employed tandem mass spectrometry to perform unbiased
proteomic analysis. We found that CNTF—a growth factor
known for promoting Schwann cell differentiation (Reynolds
and Woolf, 1993), was 5.5-fold enriched in endoneurial tissue
compared to spinal cord tissue (Figure 4A). We validated CNTF
expression with immunohistochemistry on mouse and human
adult uninjured nerves and found CNTF immunoreactivity
restricted to cytoplasmic-rich regions of myelinating Schwann
cells – most obviously at the perinuclear area (Figure 4B).
Most importantly, we found that application of CNTF alone
on iSCs in vitro caused a striking dose-dependent reduction in
proliferation (Figure 4C). Quantification of this effect revealed
up to a sixfold reduction in the percentage of Ki67+ iSCs when
treated with 100ng/ml CNTF (One-way ANOVA, Tukey’s posthoc
test, n = 3, ∗∗p < 0.05) (Figure 4D). Taken together, CNTF
appears to be an important regulator of oncogenic Schwann cells
and this data suggests that CNTF or small molecules targeting
its downstream targets, may offer some therapeutic value toward
controlling aberrant Schwann cells and MPNSTs.
DISCUSSION
These studies provide several major findings that has implications
for MPNST and consequently peripheral nerve regeneration.
First, we developed a reproducible in vitro model to study
MPNST from isolated adult Schwann cells (termed iSCs) that
following transplantation, share striking phenotypic resemblance
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FIGURE 3 | The fascicular microenvironment suppresses tumor-associated protein expression in MPNST. (A) Representative immunohistochemical images of the
endoneurial and epineurial compartments. Note the presence of widespread Ncad+ (red), Hoechst+ (blue) iSC (green) in the epineurial compartment (inset)
compared to the endoneurial compartment (arrow). See inset for high-resolution example of colocalization of proteins. (B) Quantification of the percentage of Ncad+
iSCs in endoneurial and epineurial compartments demonstrated a significant decrease in endoneurial compartment (Student’s t-test, n = 4, ∗∗∗p < 0.0008).
(C) Representative immunohistochemical images of the endoneurial and epineurial compartment. Note the presence of widespread ErbB3+ (red), Hoechst+ (blue)
iSC (green) in the epineurium (insert) compared to the endoneurium (arrows). See inset for high-resolution example of colocalization of proteins. Scale bars = A
(20 µm), C (10 µm), Insets (10 µm, A; 5 µm, C).
to primary human MPNST tumors. Second, our results
underscore the importance of regional microenvironments in
promoting tumorigenic growth and identify the endoneurial
compartment within the peripheral nerve as a unique
microenvironment enriched in tumor suppressive factors.
Third, by probing uniquely expressed proteins within the
endoneurial compartment, we demonstrated an autonomous
role for CNTF to block proliferation of iSCs mimicking the
inhibition observed when grafted iSCs are contained within the
endoneurial compartment in vivo. Together, these experiments
underscore the plasticity of iSC, highlights their sensitivity to
microenvironment, and identifies CNTF signaling as a potential
therapeutic avenue for MPNST.
Therapeutic approaches that take advantage of the
responsiveness of tumor forming cells to CNTF offers a
promising approach to treat MPNST. First, tumor-forming cells
remain responsive to this growth factor—which is already a
potentially valuable finding given the large amount of pathogenic
pathways present within cancer cells (Birindelli et al., 2001).
Moreover, given the well-described role of CNTF-induced
differentiation in healthy cells (Rathje et al., 2011; Johnson et al.,
2014), we suspect that CNTF-induced cell cycle arrest in iSCs
likely takes advantage of differentiation-induced cell cycle arrest,
which has for a long time been a promising avenue to treat
cancer (Nguyen et al., 2016). Like in MPNST, in normal health
following nerve injury, proliferation of Schwann cells also occurs.
But in contrast to the uncontrollable Schwann cell proliferation
that occurs in MPNST, in normal health, these Schwann cells
have the capacity to transition back into a mature differentiated
myelinating state and contribute to regeneration. It is possible
that CNTF-induced cell cycle arrest of iSCs piggy-backs on
similar molecular pathways as regenerative-induced cell cycle
arrest in normal health, but further study is needed.
Malignant peripheral nerve sheath tumors are mostly resistant
to current standards of treatment (Ferner and Gutmann, 2002;
Zehou et al., 2013), and surgical removal is often inadequate
and debilitating as major nerves are sacrificed, given that the
MPNST is often in close proximity to or in association with
major nerves (Plotkin et al., 2013). At present, there are few
early-stage diagnostic features that can adequately predict the
risk of MPNST. In recent years, there have been several attempts
to better understand the genetic bases of MPNST with the
hope that this knowledge could be used for early detection,
better predictions, and the discovery of new therapeutic targets.
Recently, Rahrmann et al. (2013) used an animal model approach
to investigate several likely genetic links (NF1, Pten, and EGFR)
for PNSTs, finding that a subset of genes were key players in the
formation of high-grade PNSTs (otherwise known as MPNST).
Unfortunately, identified genes only partially accounted for
the progression of benign tumors toward high-grade PNST
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FIGURE 4 | The identification of suppressive factors in the endoneurial compartment. (A) Fold change in candidate proteins (10–60 kDa) enriched in the
endoneurium compared to spinal cord tissue. Ciliary neurotrophic factor (CNTF, red box), a growth factor known for its role in promoting differentiation of Schwann
cells, was found at levels 5.5-fold higher in endoneurium tissue compared to spinal cord tissue. (B) Representative immunohistochemical images of uninjured mouse
and human sciatic nerves demonstrating the presence of CNTF (red) in the cytoplasm of Schwann cells (blue). Note the presence of CNTF around the peri-nuclear
area adjacent to nuclei (blue)—a cytoplasmic rich region of the myelinating Schwann cell. (C) Representative immunocytochemical images of iSCs (blue) treated with
0 ng/ml and 100 ng/ml CNTF. Note the reduction in Ki67+ (red) cells in CNTF treated conditions. (D) Quantification of the percentage of Ki67+ cells treated with 0,
10, or 100 ng/ml CNTF revealed a reduction in ki67+ cells at 100 ng/ml compared to 0 ng/ml (One-way ANOVA, Tukey’s posthoc test, n = 3, ∗∗p < 0.05). Scale
bars = B (25 µm), C (50 µm).
formation and in most cases only when there was a combination
of forced genetic mutations. Rodents generally formed either
benign PNSTs, such as neurofibromas, or no tumors at all. Taken
together, such findings suggest that, although there may be some
genetic characteristics of MPNST, these characteristics do not
autonomously dictate outcome. Rather, additional contributors,
such as, epigenetic and environmental factors, must also play a
role in MPNST development.
Our results support the notion that the cellular
microenvironment plays a key role in predictability of tumor
formation. When Ribiero and colleagues first made the seminal
discovery that NF1-mutant Schwann cells only formed tumors
post-injury, a logical conclusion for this phenomenon was
an environmental cue associated with the injury must also
play a role. Indeed there are several factors associated with
injury (Gaudet et al., 2011) as well as associated with tumor
progression (Brossier and Carroll, 2012) that overlap. Most
researched, in relation to PNST, is the mast cell (Yang et al.,
2008). But, in addition to mast cells, there are many other
injury-associated factors that influence cancer cells. Regulatory
T-cells thrive in the cancerous microenvironment, producing
excess TGFβ1, preventing the proliferation of other immune
cells reducing immune responses to tumors, as well as enhancing
tumor cell proliferation (Franco et al., 2016). In addition,
cancer associated fibroblasts (CAFs) have the ability to regulate
malignant growth (Erez et al., 2010; Xing et al., 2010). Finally,
another influencing factor for tumor progression is low pH
(Jahde et al., 1982)— also known to be regulated in injury
(Lengheden and Jansson, 1995). The fact that there is so much
overlap with injury-associated factors and factors known to
promote tumorigenesis, presupposes relationships between
these factors and tumor progression (Brossier and Carroll,
2012). Interestingly, though Ribeiro et al. (2013) found that
tumors did not form distal to the injury site – an area of
the nerve that undergoes Wallerian degeneration post-injury
and is, therefore, subject to similar injury cues, including
the presence of mast cells and much of the factors described
above (Gaudet et al., 2011). Such findings suggest that injury-
associated factors are not the only mechanism at play in
injury-associated Schwann cell-derived nerve sheath tumor
progression. Consistent with Ribeiro et al. (2013), our results
demonstrate that iSCs injected into the endoneurium of the
distal stump, where injury cues are widespread, does not result in
tumor formation. Together, such findings suggest that exposure
to other factors at the injury site may be triggering malignant
growth.
The fact that the perineurium is compromised when nerve
injury occurs, resulting in long term dysfunction of the
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perineurium, including a chronic increase in permeability, but
only at the injury site and not distally (Haftek and Thomas,
1968; Olsson and Kristensson, 1973) makes it plausible that
a compromised nerve-barrier might contribute to Schwann
cell-derived tumor formation and progression. Usually this
specialized perineurial barrier prevents fibroblast-derived and
adipocyte-derived factors, as well as large amounts of collagen
in the epineurium (Sunderland, 1945; Riccardi, 2007; Weiss
et al., 2016) to diffuse freely within the endoneurium where
widespread Schwann cells are present (Norris et al., 1985;
Verheijen et al., 2003). Given that several papers have shown
that factors within the epineurial compartment can lead to
tumor progression (Fang et al., 2014; Kuzet and Gaggioli,
2016; McDonald et al., 2016); and that factors within the
endoneurial compartment reduce Schwann cell proliferation
(Parrinello et al., 2008), including CNTF, it is not surprising
that we have found that iSCs are highly tumorigenic in
the epineurial compartment compared to the endoneurial
compartment. Taken together, this dataset suggests that in order
for tumor progression to occur, the growth-promoting factors
within the epineurium override suppressive factors within the
endoneurium, ultimately driving tumor formation in peripheral
nerves.
Finally, our data offers a cautionary note regarding the
use of adult Schwann cells for stem cell transplant-based
therapies to treat nervous system injury and disease. Our
work demonstrates that these cells can exhibit genomic
instability and readily acquire aberrations following repeated
in vitro expansion resulting in uncontrolled growth. As such,
we strongly believe that adult Schwann cells, isolated from
patients for subsequent autologous nervous system transplants,
should undergo minimal in vitro processing, and be subjected
to rigorous genetic screening before re-introduction into
patients.
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